Hepatitis C Drugs Market Global Forecast By Drugs, Distribution Channels, Regions, Company Analysis
Get Free Customization in This Report
Hepatitis C is a viral infection that causes severe damage to the human body; it is an infection caused by a virus that damages the liver, which leads to inflammation. It spread through contaminated blood. The prevalence of hepatitis C infection among the global populace is escalating. This is mainly caused by sharing needles, unsterilized medical equipment, and a blood transfusion from infected mothers to newborn babies. As per Renub Research Analysis, the Global Hepatitis C Drugs Market would be US$ 5.9 Billion by 2025.
In recent years, several drugs have been launched due to the high prevalence of Hepatitis C across the globe. The newly launched drug by AbbiVie i.e., Mavyret, has led to a downfall in the revenue of one of the market leader i.e. Gilead’s. Mavyret has several advantages compared to other drugs such as its treatment course is shorter, and it is much cheaper. Harvoni drugs are popular in India, and it's easier affordable among the public.
Oral injections and dosages are required weekly in Hepatitis C; at the same time, its side effects can lead to permanent damage of other organs of patients. Around the globe, many clinical trials, as well as numerous successful drug clearances, give traction to this market. Apart from that, the rising number of regulatory approvals will further boost the market during the forecast time frame.
Hepatitis C drugs have witnessed numerous drug approvals likewise, in the year 2019, USFDA approves Mavyret for the treatment of pediatric hepatitis patients. For the treatment of all genotypes of Hepatitis C, Mavyret was the first treatment.
In the North American region, rising adoption of hepatitis C drugs will favor the surging of the market. The market share of Asia – Pacific’s and Latin American regions will grow during the forecast period.
Renub Research report titled “Hepatitis C Drugs Market Global Forecast By Drugs (Mavyret, Viekira Pak, Harvoni, Epclusa, Sovaldi, Vosevi, Zepatier, Others), Distribution Channels (Hospital Pharmacies, Retail Pharmacies, Online Pharmacy), Regions (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), Company Analysis (Abbvie, Gilead Sciences, Merck, Bristol-Myers Squibb, Others)” provides a complete analysis Hepatitis C market globally.
Mavyret is the leading drug in the global hepatitis C market
Complete analysis of 7 drugs Mavyret, Viekira Pak, Harvoni, Epclusa, Sovaldi, Vosevi, Zepatier, Others is given in the report. Mavyret is the leading drug in the global hepatitis C market.
Distribution Channel is dominated by Hospital Pharmacies in the Global Hepatitis C Drugs Market
Distribution channels like Hospital Pharmacies, Retail Pharmacies & Online Pharmacy are covered in this research report. Hospital Pharmacies is the leading distribution channel in the global hepatitis C drug market.
North America and Europe are the top two leading regions in the Global Hepatitis C Drugs Market
The report studies the hepatitis C drug market of the following regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America and Europe are the top two leading regions in the global hepatitis C drug market.
All the companies have been studied from two points
• Recent Developments
• Sales Analysis
By Company - Global Hepatitis C Drugs Market
• Abbvie
• Gilead Sciences, Inc.
• Merck & Co. Inc.
• Bristol-Myers Squibb
• Others
By Regions - Global Hepatitis C Drugs Market
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
By Drugs - Global Hepatitis C Drugs Market
• Mavyret
• Viekira Pak
• Harvoni
• Epclusa
• Sovaldi
• Vosevi
• Zepatier
• Others
By Distribution Channels - Global Hepatitis C Drugs Market
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacy
If the information you seek is not included in the current scope of the study kindly share your specific requirements with our custom research team at info@renub.com
1. Introduction
2. Research & Methodology
3. Executive Summary
4. Market Dynamic
4.1 Growth Driver
4.2 Challenges
5. Global Hepatitis C Drugs Market
6. Market Share Analysis - Global Hepatitis C Drugs
6.1 Regions
6.2 Drugs
6.3 Distribution Channels
6.4 Company
7. Regions - Global Hepatitis C Drugs Market
7.1 North America
7.2 Europe
7.3 Asia Pacific
7.4 Latin America
7.5 Middle East & Africa
8. Drugs - Global Hepatitis C Drugs Market
8.1 Mavyret
8.2 Viekira Pak
8.3 Harvoni
8.4 Epclusa
8.5 Sovaldi
8.6 Vosevi
8.7 Zepatier
8.8 Others
9. Distribution Channels - Global Hepatitis C Drugs Market
9.1 Hospital Pharmacies
9.2 Retail Pharmacies
9.3 Online Pharmacy
10. Merger and Acquisitions
11. Company Analysis - Global Hepatitis C Drugs Market
11.1 Abbvie
11.1.1 Recent Development or Strategy
11.1.2 Revenue
11.2 Gilead Sciences, Inc.
11.2.1 Recent Development or Strategy
11.2.2 Revenue
11.3 Merck & Co. Inc.
11.3.1 Recent Development or Strategy
11.3.2 Revenue
11.4 Bristol-Myers Squibb
11.4.1 Recent Development or Strategy
11.4.2 Revenue
11.5 Others
List of Figures:
Figure-01: Global Hepatitis C Drug Market, (Billion US$), 2016 - 2019
Figure-02: Global Hepatitis C Drug Market Forecast, (Billion US$), 2020 - 2025
Figure-03: Global - Hepatitis C Drugs Market Share Analysis by Regions (Percent), 2016 – 2019
Figure-04: Global - Forecast for Hepatitis C Drugs Market Share Analysis by Regions (Percent), 2020 – 2025
Figure-05: Global - Hepatitis C Drugs Market Share Analysis by Distribution Channels(Percent), 2016 – 2019
Figure-06: Global - Forecast for Hepatitis C Drugs Market Share Analysis by Distribution Channels (Percent), 2020 – 2025
Figure-07: North America – Hepatitis C Drug Market, (Million US$), 2016 - 2019
Figure-08: North America – Forecast for Hepatitis C Drug Market, (Million US$), 2020 - 2025
Figure-09: Europe – Hepatitis C Drug Market, (Million US$), 2016 - 2019
Figure-10: Europe – Forecast for Hepatitis C Drug Market, (Million US$), 2020 - 2025
Figure-11: Asia Pacific– Hepatitis C Drug Market, (Million US$), 2016 - 2019
Figure-12: Asia Pacific– Forecast Hepatitis C Drug Market, (Million US$), 2020- 2025
Figure-13: Latin America – Hepatitis C Drug Market, (Million US$), 2016 - 2019
Figure-14: Latin America – Forecast Hepatitis C Drug Market, (Million US$), 2020 - 2025
Figure-15: Middle East & Africa – Hepatitis C Drug Market, (Million US$), 2016 - 2019
Figure-16: Middle East & Africa – Forecast Hepatitis C Drug Market, (Million US$), 2020 - 2025
Figure-17: Mavyret – Hepatitis C Drug Market, (Million US$), 2017 - 2019
Figure-18: Mavyret – Forecast for Hepatitis C Drug Market, (Million US$), 2020 - 2025
Figure-19: Viekira Pak – Hepatitis C Drug Market, (Million US$), 2016 2019
Figure-20: Viekira Pak – Forecast for Hepatitis C Drug Market, (Million US$), 2020 -2025
Figure-21: Harvoni–Hepatitis C Drug Market, (Million US$), 2016- 2019
Figure-22: Harvoni – Forecast Hepatitis C Drug Market, (Million US$), 2020 - 2025
Figure-23: Epclusa – Hepatitis C Drug Market, (Million US$), 2016 - 2019
Figure-24: Epclusa– Forecast Hepatitis C Drug Market, (Million US$), 2020 - 2025
Figure-25: Sovaldi– Hepatitis C Drug Market, (Million US$), 2016 - 2019
Figure-26: Sovaldi– Forecast Hepatitis C Drug Market, (Million US$), 2020 - 2025
Figure-27: Vosevi– Hepatitis C Drug Market, (Million US$), 2017- 2019
Figure-28: Vosevi– Forecast Hepatitis C Drug Market, (Million US$), 2020 - 2025
Figure-29: Zepatier–Hepatitis C Drug Market, (Million US$), 2016 - 2019
Figure-30: Zepatier – Forecast for Hepatitis C Drug Market, (Million US$), 2020 - 2025
Figure-31: By Distribution Channels - Hospital Pharmacies Market (Million US$), 2016 – 2019
Figure-32: By Distribution Channels - Forecast For Hospital Pharmacies Market (Million US$), 2020 – 2025
Figure-33: By Distribution Channels - Retail Pharmacies Market (Million US$), 2016 – 2019
Figure-34: By Distribution Channels - Forecast For Retail Pharmacies Market (Million US$), 2020 – 2025
Figure-35: By Distribution Channels - Online Pharmacy Market (Million US$), 2016 – 2019
Figure-36: By Distribution Channels - Forecast For Retail Pharmacies Market (Million US$), 2020 – 2025
Figure-37: Global - Abbvie Company Revenue Market (Million US$), 2016 – 2019
Figure-38: Global - Abbvie Company Forecasted Revenue (Million US$), 2020 – 2025
Figure-39: Global - Gilead Sciences, Inc Revenue (Million US$), 2016 – 2019
Figure-40: Global - Gilead Sciences, Inc Forecasted Revenue (Million US$), 2020 – 2025
Figure-41: Global - Merck & Co. Inc. Company Revenue (Million US$), 2016 – 2019
Figure-42: Global - Merck & Co. Inc. Company Forecasted Revenue (Million US$), 2020 – 2025
Figure-43: Global - Bristol-Myers Squibb Company Revenue (Million US$), 2016 – 2018
Figure-44: Other Company - Revenue (Million US$), 2016 – 2019
Figure-45: Other Company - Forecasted Revenue (Million US$), 2020 – 2025
List of Tables:
Table-01: Global - Hepatitis C Drugs Market Share Analysis by Drugs (Percent), 2016 – 2019
Table-02: Global - Forecast For Hepatitis C Drugs Market Share Analysis by Drugs (Percent), 2020 – 2025
Table-03: Global - Hepatitis C Drugs Market Share Analysis by Company (Percent), 2016 – 2019
Table-04: Global - Forecast for Hepatitis C Drugs Market Share Analysis by Company (Percent), 2020 – 2025
Reach out to us
Call us on
USA: +1-678-302-0700
INDIA: +91-120-421-9822
Drop us an email at
info@renub.com